{"id":"https://openalex.org/W2255928367","doi":"https://doi.org/10.1007/978-3-7643-8679-5_9","title":"The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol)","display_name":"The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol)","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2255928367","doi":"https://doi.org/10.1007/978-3-7643-8679-5_9","mag":"2255928367"},"language":"en","primary_location":{"id":"doi:10.1007/978-3-7643-8679-5_9","doi":"https://doi.org/10.1007/978-3-7643-8679-5_9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-7643-8679-5_9","pdf_url":null,"source":{"id":"https://openalex.org/S4306462920","display_name":"Birkh\u00e4user Basel eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PEGylated Protein Drugs: Basic Science and Clinical Applications","raw_type":"book-chapter"},"parent_works":[{"id":"https://openalex.org/W618357767","display_name":"PEGylated Protein Drugs: Basic Science and Clinical Applications","relationship":"volume"}],"lineage":["https://openalex.org/W2255928367","https://openalex.org/W618357767"],"child_works_count":0,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044780155","display_name":"Jonathan K. Armstrong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jonathan K. Armstrong","raw_affiliation_strings":["Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, 90033, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California, 90033, USA","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044780155"],"corresponding_institution_ids":["https://openalex.org/I1174212"],"apc_list":null,"apc_paid":null,"fwci":4.7225,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.94501018,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":null,"issue":null,"first_page":"147","last_page":"168"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.4343000054359436,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.4343000054359436,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.3237000107765198,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.06930000334978104,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.8420000076293945},{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.9330000281333923},{"id":"https://openalex.org/keywords/peg-asparaginase","display_name":"PEG-asparaginase","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.7720000147819519},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8339999914169312},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.8743075132369995},{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.8312989473342896},{"id":"https://openalex.org/C2779026604","wikidata":"https://www.wikidata.org/wiki/Q4774742","display_name":"Antigenicity","level":3,"score":0.7419759035110474},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.67235267162323},{"id":"https://openalex.org/C2777516009","wikidata":"https://www.wikidata.org/wiki/Q194207","display_name":"Ethylene glycol","level":2,"score":0.6323857307434082},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5596693754196167},{"id":"https://openalex.org/C112613896","wikidata":"https://www.wikidata.org/wiki/Q898370","display_name":"Conjugated system","level":3,"score":0.5484552383422852},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5480501651763916},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5163296461105347},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4952179491519928},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.35771191120147705},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32185786962509155},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26239603757858276},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25268271565437317},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.08892720937728882},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.06916913390159607},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-3-7643-8679-5_9","doi":"https://doi.org/10.1007/978-3-7643-8679-5_9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-7643-8679-5_9","pdf_url":null,"source":{"id":"https://openalex.org/S4306462920","display_name":"Birkh\u00e4user Basel eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PEGylated Protein Drugs: Basic Science and Clinical Applications","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":89,"referenced_works":["https://openalex.org/W98666424","https://openalex.org/W130297679","https://openalex.org/W198567551","https://openalex.org/W270770744","https://openalex.org/W376157301","https://openalex.org/W630513080","https://openalex.org/W1490299254","https://openalex.org/W1555210583","https://openalex.org/W1561844029","https://openalex.org/W1852491077","https://openalex.org/W1918944513","https://openalex.org/W1965067289","https://openalex.org/W1969101688","https://openalex.org/W1970523181","https://openalex.org/W1971567758","https://openalex.org/W1972681888","https://openalex.org/W1974526584","https://openalex.org/W1977701499","https://openalex.org/W1978731039","https://openalex.org/W1981373522","https://openalex.org/W1983898741","https://openalex.org/W1984047841","https://openalex.org/W1987065191","https://openalex.org/W1988428180","https://openalex.org/W1990622580","https://openalex.org/W1999124243","https://openalex.org/W2000104469","https://openalex.org/W2006659086","https://openalex.org/W2007102329","https://openalex.org/W2008840793","https://openalex.org/W2009785921","https://openalex.org/W2010506651","https://openalex.org/W2010528256","https://openalex.org/W2011208020","https://openalex.org/W2011370547","https://openalex.org/W2013821847","https://openalex.org/W2014576677","https://openalex.org/W2017541838","https://openalex.org/W2026207023","https://openalex.org/W2027026258","https://openalex.org/W2030951969","https://openalex.org/W2036378709","https://openalex.org/W2037808957","https://openalex.org/W2041244345","https://openalex.org/W2043499815","https://openalex.org/W2044618657","https://openalex.org/W2054018847","https://openalex.org/W2054087659","https://openalex.org/W2056318828","https://openalex.org/W2062378968","https://openalex.org/W2064331847","https://openalex.org/W2067557497","https://openalex.org/W2068561565","https://openalex.org/W2069261831","https://openalex.org/W2071448794","https://openalex.org/W2082850131","https://openalex.org/W2083431591","https://openalex.org/W2084994494","https://openalex.org/W2087167636","https://openalex.org/W2095399328","https://openalex.org/W2097980094","https://openalex.org/W2102778972","https://openalex.org/W2104278356","https://openalex.org/W2107494070","https://openalex.org/W2111237091","https://openalex.org/W2113502101","https://openalex.org/W2113653720","https://openalex.org/W2114220404","https://openalex.org/W2122941511","https://openalex.org/W2124119109","https://openalex.org/W2124140010","https://openalex.org/W2124409897","https://openalex.org/W2150552945","https://openalex.org/W2162505722","https://openalex.org/W2166171010","https://openalex.org/W2169309865","https://openalex.org/W2191845930","https://openalex.org/W2249904142","https://openalex.org/W2261162765","https://openalex.org/W2269085384","https://openalex.org/W2336924892","https://openalex.org/W2398180562","https://openalex.org/W2409343132","https://openalex.org/W2412853498","https://openalex.org/W2494381690","https://openalex.org/W2599534060","https://openalex.org/W4238576953","https://openalex.org/W4249555487","https://openalex.org/W4294576199"],"related_works":["https://openalex.org/W2096828550","https://openalex.org/W2070371670","https://openalex.org/W3198884354","https://openalex.org/W3000914255","https://openalex.org/W3137247338","https://openalex.org/W1981273187","https://openalex.org/W4391018748","https://openalex.org/W2472635460","https://openalex.org/W2911231886","https://openalex.org/W2985058683"],"abstract_inverted_index":{"Specific":[0],"antibodies":[1],"against":[2],"poly(ethylene":[3],"glycol)":[4],"(anti-PEG)":[5],"were":[6,161],"induced":[7],"in":[8,18,42,76,127],"animals":[9],"following":[10,31],"exposure":[11,32],"to":[12,33,71,78,98,114,142,153],"PEG-conjugated":[13,22,35,122],"proteins":[14],"and":[15,37,63,82,106,124,135,139,165,174],"particles,":[16],"resulting":[17],"rapid":[19,59],"clearance":[20,60,152],"of":[21,27,53,61,66,73,119,148,157],"agents.":[23],"In":[24,48],"humans,":[25],"induction":[26],"anti-PEG":[28,39,54,120,149],"was":[29,40,55],"observed":[30],"a":[34,128],"drug,":[36],"pre-existing":[38],"identified":[41],"over":[43],"25%":[44],"the":[45,51,117,144,155,168,175,181],"healthy":[46],"population.":[47],"clinical":[49],"studies,":[50],"presence":[52],"strongly":[56],"associated":[57],"with":[58],"PEG-asparaginase":[62],"PEG-uricase.":[64],"PEGylation":[65],"therapeutic":[67],"agents":[68,123],"will":[69],"continue":[70],"be":[72,133,178],"significant":[74],"value":[75],"medicine":[77],"reduce":[79],"immunogenicity,":[80],"antigenicity":[81],"toxicity":[83],"as":[84,86,180],"well":[85],"markedly":[87],"reducing":[88],"renal":[89],"clearance,":[90],"while":[91],"maintaining":[92],"drug":[93,151],"efficacy.":[94],"It":[95],"is":[96,172],"important":[97],"recognize":[99],"that":[100],"PEG":[101],"itself":[102],"may":[103,177],"possess":[104],"antigenic":[105],"immunogenic":[107],"properties.":[108],"Further":[109],"comprehensive":[110],"studies":[111],"are":[112],"warranted":[113],"fully":[115],"elucidate":[116],"effect":[118,147],"on":[121,150],"if":[125],"confirmed":[126],"prospective":[129],"trial,":[130],"patients":[131],"should":[132],"screened":[134],"monitored":[136],"for":[137],"anti-PEG,":[138],"strategies":[140],"developed":[141],"overcome":[143],"potential":[145],"negative":[146],"improve":[154],"effectiveness":[156],"therapy.":[158],"These":[159],"keywords":[160,176],"added":[162],"by":[163,167],"machine":[164],"not":[166],"authors.":[169],"This":[170],"process":[171],"experimental":[173],"updated":[179],"learning":[182],"algorithm":[183],"improves.":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2255928367","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
